683 Capital Management, LLC Bridge Bio Pharma, Inc. Transaction History
683 Capital Management, LLC
- $1.24 Billion
- Q1 2025
A detailed history of 683 Capital Management, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, 683 Capital Management, LLC holds 575,000 shares of BBIO stock, worth $19.2 Million. This represents 1.6% of its overall portfolio holdings.
Number of Shares
575,000
Previous 635,000
9.45%
Holding current value
$19.2 Million
Previous $17.4 Million
14.08%
% of portfolio
1.6%
Previous 1.25%
Shares
5 transactions
Others Institutions Holding BBIO
# of Institutions
361Shares Held
185MCall Options Held
12.8MPut Options Held
2.09M-
Viking Global Investors LP22.1MShares$735 Million2.55% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$642 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$497 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$415 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$239 Million0.14% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $4.94B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...